Morning Market Snapshot: August 27, 2010
“Good Morning. It’s Friday, August 27, 2010. At this hour, US equity futures are up. Overseas, the Asian markets were mixed, while the European markets are down. Dell increased its bid for 3Par (PAR) to $27 per share, or an enterprise value of $1.8B, an 11% premium above the most recent price offered by Hewlett-Packard…Boeing (BA) said that it now expects delivery of the first 787 in the middle of Q1 of 2011. The delivery date revision follows an assessment of the availability of an engine needed for the final phases of flight test this fall…Genentech (RHHBY) announced the FDA issued a Refuse to File letter for accelerated approval for the company’s trastuzumab-DM1, or T-DM1, Biologics License Application. In its review of the BLA, the FDA stated the T-DM1 trials did not meet the standard for accelerated approval because all available treatment choices approved for metastatic breast cancer, regardless of HER2 status, had not been exhausted in the study population…Gannett’s (GCI) USA Today confirmed an organizational restructuring, which affects the newspaper’s business operations and newsroom. In one major change, the newsroom will be broken into “”content rings,”" headed by editors who will be appointed later this year.”
Public Market packs in shoppers
Public Market packs in shoppers
Juneau residents got to take in some different flavors in their holiday shopping at the 28th annual Alaska Juneau Public Market, and they certainly took advantage of the opportunity. Centennial Hall and the Juneau Arts & Culture Center were packed with hundreds of shoppers plus vendors from across the state and beyond.
Read more on Juneau Empire
Categories: Breast Cancer Information Tags: Market, Packs, Public, shoppers
Reportlinker Adds Europe In Vitro Diagnostics Market Outlook to 2016
Reportlinker Adds Europe In Vitro Diagnostics Market Outlook to 2016
Reportlinker.com announces that a new market research report is available in its catalogue:
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Information Tags: 2016, adds, diagnostics, Europe, Market, outlook, Reportlinker, vitro
Breast Cancer Market ? An Analysis – Market Research Report on Aarkstore Enterprise
Breast cancer is the second most common type of cancer after lung cancer worldwide and the fifth most common cause of cancer death. It is found more in women as compared to men. Worldwide more than one million new cases of breast cancer are found every year. New breast cancer cases are mostly found in North America.
Breast cancer is usually found in women over the age of 40 years. Breast cancer cases have risen about 30% in the past 25 years in western countries like the US and Europe. Breast cancer market is comprised of two segments – diagnostic and therapy. The key drivers of breast cancer market are aging population, obesity and family history among others.
The stages of breast cancer are of critical importance and decide the treatment method and the extent to which it can be cured. Mammography is believed to find 85% to 90% of breast cancers in women over 50, and can discover a lesion one to four years before a lump can be felt. In case of patients with dense breast tissue, breast implants or patients who are breastfeeding, mammography cannot produce clear images and therefore, in such cases, ultrasound or MRI is recommended. Biopsy is used for the diagnosis of breast cancer once a lesion is detected in screening. For treatment of breast cancer, surgery is used first and then drugs or radiation therapy or both are used.
The major players of breast cancer market are strengthening their networks through international alliances, agreements, strategic acquisitions, exploring new markets and R&D initiatives that will help in more effective diagnosis and treatment of breast cancer.
This report provides an overview of the breast cancer, its types and stages, and incidence rates. The markets for diagnosis and treatment of breast cancer have been analyzed. Markets for diagnosis and treatment like, mammography, biopsy, chemotherapy, radiotherapy and drugs have also been discussed. The report also analyzes the drivers, issues and trends in the breast care market. The major players in the market are profiled along with their key business strategies.
Table of Contents :
1. Breast Cancer Types and Stages
Types of breast cancer
Stages of breast cancer
Survival rates at different stages of breast cancer
2. Breast Cancer Market Overview
Deaths in males/females by age group and region
New breast cancer cases in different regions of the world
US breast cancer incidence/death rates by race/color
Causes of cancer
2.1 Breast Cancer Screening, Diagnosis and Treatment
Screening, diagnosis and treatment processes
Use of drugs and therapies in treatment of breast cancer
3. Screening/Diagnostics Market
3.1 Mammography
Global mammography market and its segments
Share of different regional markets in mammography
Drivers of mammography market
Competition in the global mammography equipment market
North American mammography market and market share of main players
Role of MRIs and ultrasound
3.2 Blood-based Diagnostic Test
Blood based breast cancer diagnostic tests
Potential market in India and the UK
3.3 Biopsy Market
Global breast biopsy market size and growth
Market share of main players in the global breast biopsy market
Various breast biopsy methods
4. Breast Cancer Treatment Market
4.1 Therapy Market
Use of therapies at different stages of breast cancer
4.1.1 Radiotherapy Market
Market share of main players in radiation therapy market
4.1.2 Chemotherapy and Taxane Drugs Market
Global Taxane drug market size
Abraxane drug market size and forecast
Abraxane market share in the US
5. Market Movements
5.1 Growth drivers
5.1.1 Aging Population
5.1.2 Family history of breast cancer
5.1.3 Hormonal factors
5.1.4 High breast tissue density
5.1.5 Obesity
5.2 Key Issues
5.2.1 Mammogram radiation raises breast cancer risk in women
5.2.2 Lack of health insurers
5.3 Breast Care Market Trends
5.3.1 Advances in Imaging Technology for Screening
5.3.2 Advances in Imaging Technology for Biopsy
5.3.3 Paradigm Shift to Less Invasive Procedures
5.3.4 Emergence of Integrated Breast Centers
6. Company Profiles
6.1 Hologic Inc.
Business Overview
Business Strategies
Expanding through acquisitions
Introducing 3D digital technology
6.2 SenoRx, Inc
Business Overview
Business Strategies
Provide Differentiated, Tailored Solutions in the Breast Biopsy Market
Leveraging R&D Competencies
Pursue Strategic Acquisitions and Partnerships
6.3 Johnson and Johnson
Business Overview
Business Strategies
Acquisitions to strengthen business
Creating franchises in Pharmaceutical business
6.4 Siemens AG
Business Overview
Business Strategies
Company reorganization
Improving Healthcare worldwide
7. Metastatic Breast Cancer Forecast
For more information, please visit :
http://www.aarkstore.com/reports/Breast-Cancer-Market-An-Analysis-36164.html
Categories: Breast Cancer Mammogram Tags: Aarkstore, Analysis, breast, cancer, Enterprise, Market, Report, research
Reportlinker Adds The US Cancer Diagnostics Market
Reportlinker Adds The US Cancer Diagnostics Market
Reportlinker.com announces that a new market research report is available in its catalogue:
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Risks Tags: adds, cancer, diagnostics, Market, Reportlinker
